Startup Funding News Today, August 27, 2026: Instinct, Breedr, Agentrys & More

Venture capital moved into a remarkably broad mix of markets overnight, but one deal towers over the rest: Instinct’s $250 million Series B at a $2.5 billion valuation. The consumer AI assistant, still in private beta, accounts for most of the disclosed dollar capital in today’s selected rounds and shows that investors remain willing to place enormous early bets on AI products that could become new consumer interfaces.

Beneath that headline round, the pattern is more grounded. Investors backed semiconductor engineering automation, behavioral-health software, livestock supply-chain infrastructure, medical-device logistics, enterprise healthcare AI, quantum simulation and humanoid robotics. In Europe, several smaller rounds point to continued investor appetite for hard technical problems rather than generic software: ColibriTD is commercializing quantum simulation, while Motion is betting that humanoid robots can be sold as a managed service rather than expensive machinery that factories must integrate themselves.

Across the ten qualifying rounds identified in the latest research window, disclosed funding exceeds $340 million, excluding MiiHealth AI’s undisclosed seed round and before converting several euro-denominated financings. More striking than the total is the distribution: AI remains dominant, but much of the capital is flowing into applications tied to semiconductor design, healthcare operations, physical automation and specialized industrial workflows.

The Macro Environment: AI Capital Moves Into Specialized Work

The venture market is increasingly distinguishing between AI products that simply expose a model and companies that control a difficult workflow. Agentrys is attacking semiconductor engineering, where verification and physical design remain expensive and labor-intensive. Onos Health is applying AI to behavioral-health utilization and clinical decision support. MiiHealth AI is automating patient intake and writing structured information into electronic health records. These companies are selling into areas where mistakes have financial or operational consequences, making specialized data and workflow knowledge more valuable.

Instinct represents the opposite end of the market: a horizontal consumer AI assistant. Its $250 million Series B was co-led by Index Ventures and Benchmark, valuing the young company at $2.5 billion. That pricing indicates investors still believe there may be room for a major consumer interface outside the established model providers. But the size of the bet also raises the bar: a private-beta assistant carrying a multibillion-dollar valuation will eventually have to turn user enthusiasm into large-scale retention and revenue.

Physical technology is another recurring theme. Motion is turning humanoid deployment into a subscription-like service that bundles robots, training, integration, insurance and maintenance. Breedr is digitizing cattle records and commerce across a supply chain that still contains significant offline friction. The common investment thesis is that software creates more value when it becomes embedded in difficult real-world operations.

Quantum computing also appears in today’s mix, but in an increasingly pragmatic form. ColibriTD is not asking investors to finance another quantum computer. It is building simulation software that can work across hardware and target industrial problems such as fluid dynamics, semiconductor design, aerospace engineering and quantitative finance. That software-layer strategy may become increasingly attractive as competing quantum architectures continue to mature.

Instinct raises $250M Series B in funding for its consumer AI assistant

Instinct has raised $250 million in Series B funding, bringing total funding to $350 million and valuing the company at $2.5 billion. Index Ventures and Benchmark co-led the financing. The startup operates under Spear Street Technology and is led by 23-year-old founder Noah Shinn.

Instinct is building an AI assistant intended to handle everyday tasks through connected apps and devices. The company says early users have used it to buy groceries and concert tickets, cancel subscriptions, plan road trips and even organize a wedding.

The round is important less because the personal-assistant concept is new than because of the valuation attached to it. Investors are effectively betting that the next major consumer technology platform may emerge from an AI agent that can execute tasks across existing services rather than requiring users to open multiple apps themselves.

Instinct remains in private beta, however, and privacy concerns around broad permissions illustrate the core challenge facing consumer agents: the more useful an assistant becomes, the more access it typically needs.

Funding Details

Startup: Instinct / Spear Street Technology
Investors: Index Ventures, Benchmark
Amount Raised: $250 million
Total Raised: $350 million
Funding Stage: Series B
Funding Date: August 26, 2026
Headquarters: Not disclosed
Sector: Consumer AI / AI agents
Valuation: $2.5 billion

Breedr raises $27 million in funding to digitize the livestock supply chain

Breedr raised $27 million in Series B funding led by Partech’s impact fund, with participation from Latitude, LocalGlobe’s growth fund, and Outsiders Fund. The financing brings total capital raised to approximately $46.6 million.

The company gives cattle digital records that follow animals through their lifecycle, connecting production data with livestock commerce. Breedr says its platform now tracks more than two million cattle and expects nearly $500 million worth of livestock to move through its marketplace this year.

The startup is applying a familiar software thesis to an unusually physical market: better information can make fragmented supply chains easier to price, manage and finance.

Breedr is now headquartered in Texas and operates across the U.S., UK and Australia, with expansion into New Zealand underway.

Funding Details

Startup: Breedr
Investors: Partech, Latitude, LocalGlobe, Outsiders Fund
Amount Raised: $27 million / approximately €23 million
Total Raised: Approximately $46.6 million
Funding Stage: Series B
Funding Date: August 27, 2026
Headquarters: Texas
Sector: Agtech / livestock technology
Valuation: Not disclosed

Agentrys raises $24.5M to automate semiconductor engineering with AI agents

Agentrys has raised $24.5 million across pre-seed and seed financing, including a $19.1 million seed round led by Etna Capital and an earlier $5.4 million pre-seed investment led by MediaTek.

The startup is building AI agents for semiconductor engineering, targeting workflows including verification and physical design. Chip design remains one of technology’s most specialized engineering disciplines, and rising processor complexity is increasing the amount of work required before a chip reaches manufacturing.

That makes semiconductor automation a particularly attractive AI market. Even modest productivity improvements can have substantial economic value when engineering teams are expensive, and development cycles determine when billion-dollar chip programs reach market.

MediaTek’s participation also adds a strategic dimension. A chipmaker investing at the pre-seed stage suggests interest from potential users, not just financial investors.

Funding Details

Startup: Agentrys
Investors: Etna Capital, MediaTek
Amount Raised: $24.5 million
Total Raised: $24.5 million
Funding Stage: Seed plus pre-seed
Funding Date: August 26, 2026
Headquarters: Not disclosed
Sector: Semiconductor AI/engineering automation
Valuation: Not disclosed

Hike Medical raises $22.5M to automate orthotics and medical-device referrals

Hike Medical raised $22.5 million in seed and Series A funding to expand an automated referral and supply-chain platform serving orthotics, prosthetics and durable medical equipment. Saga Ventures led the financing, with participation from Indicator Ventures, Fifth Down Capital, RiverPark Ventures, Orthofeet and several individual investors.

The company is attacking a healthcare problem that receives far less attention than drug discovery: getting physical medical devices from providers to patients efficiently.

Hike says it has already applied its model to custom foot orthotics and now wants to extend the platform across device-based care. The opportunity sits at the intersection of healthcare administration, logistics and workflow software.

Investors have increasingly targeted healthcare’s administrative layer because labor costs and fragmented software systems leave large pools of spending that technology can potentially reduce without requiring scientific breakthroughs.

Funding Details

Startup: Hike Medical
Investors: Saga Ventures, Indicator Ventures, Fifth Down Capital, RiverPark Ventures, Orthofeet and others
Amount Raised: $22.5 million
Total Raised: Not disclosed
Funding Stage: Seed and Series A
Funding Date: August 26, 2026
Headquarters: San Francisco, California
Sector: Healthtech / medical-device logistics
Valuation: Not disclosed

Onos Health raises $17M for AI-powered behavioral-health intelligence

Onos Health raised $17 million in Series A financing led by Costanoa Ventures, with participation from Flare Capital Partners and CVS Health Ventures.

The startup provides clinical intelligence software for behavioral-health plans, using AI to analyze care patterns and improve decisions around treatment and spending. Aetna is among the health plans using the platform, the company says.

Behavioral healthcare is a large but operationally difficult market. Insurers have substantial incentives to improve outcomes while identifying unnecessary or ineffective spending, but decisions require clinical context rather than simple claims automation.

That makes Onos an example of a broader shift in healthcare AI: investors are moving beyond administrative copilots toward software that influences how care resources are allocated.

Funding Details

Startup: Onos Health
Investors: Costanoa Ventures, Flare Capital Partners, CVS Health Ventures
Amount Raised: $17 million
Total Raised: Not disclosed
Funding Stage: Series A
Funding Date: August 27, 2026
Headquarters: United States
Sector: Healthcare AI / behavioral health
Valuation: Not disclosed

ColibriTD raises €4M to commercialize quantum-powered simulation

Paris-based ColibriTD raised €4 million in seed financing led by Earlybird Venture Capital, with SymbiaVC and Medin VC participating. Earlybird had previously invested €1 million at the pre-seed stage.

ColibriTD builds software for multiphysics simulation using its H-DES hybrid differential equation solver. Partial differential equations underpin simulations across aerospace, fluid mechanics, semiconductor engineering, energy systems and financial modeling.

Rather than tying its business to one quantum hardware company, ColibriTD is pursuing a hardware-agnostic approach. The company says it has completed projects in defense, aerospace, space, semiconductors, nuclear energy, automotive engineering and finance.

If quantum computing delivers commercial advantages before large fault-tolerant machines become widespread, software that translates specialized industrial problems across different quantum systems could become a valuable layer of the stack.

Funding Details

Startup: ColibriTD
Investors: Earlybird Venture Capital, SymbiaVC, Medin VC
Amount Raised: €4 million
Total Raised: At least €5 million disclosed
Funding Stage: Seed
Funding Date: August 27, 2026
Headquarters: Paris, France
Sector: Quantum software / industrial simulation
Valuation: Not disclosed

Solace Care raises €2.1M to build end-of-life insurance infrastructure

Stockholm-based Solace Care raised €2.1 million in pre-seed funding, led by Spintop Ventures, with Plug and Play, Further Than Capital, Wave Ventures and several angel investors participating.

The startup is developing an end-of-life platform distributed through insurers and brokers. It plans to use the funding to deepen partnerships across the Nordic region and expand into the Netherlands and UK.

Insurance distribution makes the company more interesting than a standalone consumer application. By embedding its service into policies and broker relationships, Solace can potentially reach customers through established financial channels rather than acquiring them individually.

That distribution model may become especially important for startups addressing sensitive or low-frequency life events where direct consumer acquisition is expensive.

Funding Details

Startup: Solace Care
Investors: Spintop Ventures, Plug and Play, Further Than Capital, Wave Ventures and angels
Amount Raised: €2.1 million
Total Raised: Not disclosed
Funding Stage: Pre-seed
Funding Date: August 27, 2026
Headquarters: Stockholm, Sweden
Sector: Insurtech / end-of-life services
Valuation: Not disclosed

Motion raises €1.7M to bring humanoid robots to factories as a service

Brussels-based Motion raised €1.7 million in pre-seed funding led by Extantia Capital, with Norrsken Evolve participating.

Motion describes itself as a Humanoids-as-a-Service platform. Instead of requiring manufacturers to buy robots and build internal robotics expertise, the startup bundles robot selection, financing, task training, software integration, insurance, compliance and maintenance into a monthly service.

The company says it already has five industrial, warehouse and logistics pilots and aims to deploy hundreds of robots across Europe over the next year.

The model addresses an important problem in humanoid robotics: even if the hardware works, adoption can stall because customers must integrate unfamiliar machines into production systems. Motion is betting that deployment expertise becomes its own defensible layer.

Funding Details

Startup: Motion
Investors: Extantia Capital, Norrsken Evolve
Amount Raised: €1.7 million / approximately $2 million
Total Raised: €1.7 million
Funding Stage: Pre-seed
Funding Date: August 27, 2026
Headquarters: Brussels, Belgium
Sector: Humanoid robotics / industrial automation
Valuation: Not disclosed

ArcSpace secures more than €2M for satellite servicing

French space startup ArcSpace secured more than €2 million to develop technology to service and repair satellites in orbit. The financing was reported as part of Europe’s August 27 funding activity.

In-orbit servicing is becoming a more credible commercial category as satellite constellations grow and spacecraft become more expensive and strategically important. The ability to inspect, repair, or potentially extend the useful life of satellites could reduce replacement costs while creating a new layer of space infrastructure.

The market also has defense and sovereignty implications. Governments increasingly view space assets as critical infrastructure, raising the strategic value of technologies that can maintain those assets after launch.

Funding Details

Startup: ArcSpace
Investors: Not fully disclosed in available reporting
Amount Raised: More than €2 million
Total Raised: Not disclosed
Funding Stage: Not disclosed
Funding Date: August 27, 2026
Headquarters: France
Sector: Space technology / in-orbit servicing
Valuation: Not disclosed

MiiHealth AI raises seed funding to automate patient intake

MiiHealth AI closed a seed funding round for an undisclosed amount led by Russell Glass through Arteria Capital, with physician angels, healthcare operators and digital-health founders also participating.

The company is building an AI medical assistant that calls patients before appointments, collects clinical history and writes structured intake notes into electronic health records.

The use case is mundane compared with AI drug discovery, but that may be precisely why it is commercially attractive. Patient intake consumes staff time across nearly every outpatient healthcare organization, and the workflow is structured enough to automate while still requiring integration with clinical systems.

MiiHealth illustrates a wider investment pattern: healthcare AI companies are increasingly targeting narrow workflows where customers can measure labor savings rather than promising a complete reinvention of medicine.

Funding Details

Startup: MiiHealth AI
Investors: Arteria Capital, physician angels, and healthcare operators
Amount Raised: Not disclosed
Total Raised: Not disclosed
Funding Stage: Seed
Funding Date: August 26, 2026
Headquarters: Phoenix, Arizona
Sector: Healthcare AI / clinical workflow automation
Valuation: Not disclosed

What Today’s Funding Activity Reveals

The most striking characteristic of today’s funding is the gulf between one enormous consumer AI bet and a long tail of specialized technology businesses.

Instinct alone accounts for most of the disclosed dollar capital in today’s selected rounds. That concentration means the aggregate funding number should not be interpreted as evidence that every category is suddenly flush with capital.

Outside Instinct, investors are writing much smaller checks to companies with sharply defined markets: chip engineering, behavioral health, livestock commerce, medical-device logistics, quantum simulation, and factory robotics.

That suggests venture capital is currently supporting two distinct AI strategies.

The first is platform-scale ambition, where investors tolerate extraordinary valuations because they believe a company could become a new consumer or enterprise interface.

The second is workflow ownership, where startups win because they understand a specialized process deeply enough to automate work that generic AI systems cannot handle reliably on their own.

Physical-world software also continues to attract capital. Breedr and Motion show that investors remain interested in industries where digitization has lagged consumer and enterprise software. Those markets can be harder to enter, but operational complexity itself creates barriers to competitors.

Finally, the presence of ColibriTD and ArcSpace shows that investors are still willing to finance technologies whose commercial adoption depends on larger infrastructure shifts. Quantum computing and in-orbit servicing remain early markets, but investors are increasingly backing software and services that could benefit before the underlying hardware reaches full maturity.

Comparative Funding Table

Strategic Takeaways for Founders and Investors

AI differentiation is moving deeper into workflows. Agentrys, Onos Health and MiiHealth are not competing on the quality of a general-purpose chatbot. Their value depends on understanding semiconductor development, behavioral-health economics or clinical operations.

Distribution can be as valuable as technology. Breedr sits inside livestock commerce. Solace wants insurers and brokers as distribution partners. Hike Medical sits between providers and medical-device supply chains. Those positions can create customer relationships that are harder to displace than a standalone application.

Strategic investors remain important in technically demanding markets. MediaTek’s early participation in Agentrys gives the semiconductor startup a connection to an industry player that understands the workflow it wants to automate. CVS Health Ventures’ participation in Onos offers a similar signal in healthcare.

Physical AI may create a deployment economy around the robots themselves. Motion’s business assumes manufacturers do not necessarily want to become robotics experts. If humanoids become interchangeable hardware, financing, integration, fleet management, and compliance could become substantial businesses around them.

Huge valuations still require huge outcomes. Instinct’s $2.5 billion valuation shows that consumer AI still commands exceptional investor enthusiasm. It also means the company must eventually support expectations that look more like a future platform than an ordinary application.

Conclusion

Today’s funding activity is a useful reminder that venture capital’s AI thesis is widening, not disappearing.

The largest check went to a consumer AI assistant with ambitions to become an interface for everyday life. But most of the remaining companies are doing something very different: applying software and AI to tightly defined markets where domain knowledge, distribution, hardware integration or proprietary workflows matter.

That may be the more durable signal from August 27.

Capital is still chasing AI, but increasingly it is paying for AI attached to something difficult: semiconductor engineering, clinical workflows, livestock networks, factory operations, quantum simulation or physical infrastructure.